Author

B. Panthu

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:human· 2 Approach:statistical model· 2 Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1

Frequent Co-Authors

A. Aublin-Gex· 1 shared A. Vincent· 1 shared C. Jacquemin· 1 shared C. Machon· 1 shared F. Catez· 1 shared F. Laforets· 1 shared F. V. Filipp· 1 shared G. J. P. Rautureau· 1 shared

Activity by Year

2020-2020 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

A. Aublin-Gex

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Alteration of ribosome function upon 5-fluorouracil treatment favours cancer cell drug-tolerance

G. Therizols, Z. Bash-Imam, B. Panthu, C. Machon, A. Vincent, S. Nait Slimane, M. Garcia, F. Laforets, V. Marcel, J. Boubaker-Vitre, G. Souahlia, M.-A. Albaret, H. C. Mertani, M. Prudhomme, M. Bertrand, , J.-J. Diaz

This study shows that 5-FU treatment creates fluorinated ribosomes that selectively translate survival genes, promoting drug tolerance in cancer cells.

bioRxiv · Jun 4, 2020 · PreprintCancer Biology

Lipogenesis and innate immunity in hepatocellular carcinoma cells reprogrammed by an isoenzyme switch of hexokinases

L. Perrin-Cocon, P.-O. Vidalain, C. Jacquemin, A. Aublin-Gex, K. Olmstead, B. Panthu, G. J. P. Rautureau, P. Andre, P. Nyczka, M.-T. Hutt, N. Amoedo, R. Rossignol, F. V. Filipp, V. Lotteau, O. Diaz

This study shows that switching hexokinase isoenzymes in HCC cells alters metabolism and reactivates innate immunity, improving survival outcomes.

bioRxiv · Mar 13, 2020 · PreprintCancer Biology